Publications by authors named "F G de Burgos"

Background: Amazonas is a region in northern Peru with the second-highest incidence of malaria. Approximately 95% of the cases are reported in the Condorcanqui province, where native communities living along the banks of Santiago River lack access to potable water, sewage, and electricity. This study aimed to analyse malaria's spatial, temporal, and climatic characteristics in Condorcanqui to guide future studies and prevention strategies.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the rise in dengue cases in Amazonas, Peru, from 2021 to 2023, focusing on the circulating serotypes and their clinical features.
  • Out of 420 serum samples tested, DENV-1 was found in 194 patients and DENV-2 in 226, with both serotypes present in all tested provinces.
  • DENV-2 was linked to more severe warning signs and abdominal pain, indicating a need for improved real-time monitoring to predict disease severity.
View Article and Find Full Text PDF

Introduction: The tetravalent live virus vaccine developed by Takeda called Qdenga® is available in Argentina and approved for use from 4 years of age without age limit. The objective was to describe clinical characteristics and evolution of the initial reports of rash after the first dose.

Material And Methods: The records of Events Supposedly Attributable to Vaccination or Immunization Reported in a Private Vaccination Center were reviewed between 15/11/2023 and 12/12/2023.

View Article and Find Full Text PDF

Objective: Florfenicol (FFC) is a broad-spectrum antibiotic approved by the U.S. Food and Drug Administration to treat both systemic and external bacterial infections in food fish.

View Article and Find Full Text PDF

Postbiotics were defined in 2021 by the International Scientific Association for Probiotics and Prebiotics (ISAPP) as a "preparation of inanimate microorganisms and/or their cellular components that confers a health benefit to the host." The field of postbiotics is a new area within the biotics family; numerous products have already been developed for clinical applications, such as immune stimulation, the management of diarrhea in children and adults, the management of irritable bowel syndrome, and 3 infant formulas. In particular, infant formulas with postbiotics obtained from milk fermented with Bifidobacterium breve C50 and Streptococcus thermophilus O65 -and their metabolites-, including the oligosaccharide 3'-GL, have demonstrated to be safe and to contribute to the development of the gut microbiota and the gutassociated immune system.

View Article and Find Full Text PDF